Handelsinvest Investeringsforvaltning’s Evolent Health EVH Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-200,000	Closed	-$1.44M	–	121
2019 Q3	$1.44M	Buy	200,000 +75,000	+60%	+$538K	0.32%	65
2019 Q2	$994K	Buy	125,000 +65,000	+108%	+$770K	0.21%	77
2019 Q1	$755K	Buy	+60,000	New	+$950K	0.17%	92
2018 Q3	–	Sell	-89,400	Closed	-$1.88M	–	109
2018 Q2	$1.88M	Hold	89,400	–	–	0.41%	54
2018 Q1	$1.27M	Hold	89,400	–	–	0.28%	57
2017 Q4	$1.1M	Hold	89,400	–	–	0.24%	68
2017 Q3	$1.59M	Hold	89,400	–	–	0.37%	53
2017 Q2	$2.27M	Buy	+89,400	New	+$2.15M	0.57%	42

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's EVH Position: Q4 2019 in Review

Handelsinvest Investeringsforvaltning sold out of Evolent Health (EVH) in Q4 2019, closing a stake of 200,000 shares — an estimated $1.44M sold.

Handelsinvest Investeringsforvaltning first reported a position in EVH in Q2 2017 and held it in 8 quarters. The position peaked at $2.27M in Q2 2017. 167 funds tracked by Wall St. Rank hold EVH as of Q4 2019.

Handelsinvest Investeringsforvaltning reported no remaining Evolent Health position as of Q4 2019 after selling out during the quarter.
Handelsinvest Investeringsforvaltning sold 200,000 Evolent Health shares in Q4 2019, an estimated $1.44M.
Handelsinvest Investeringsforvaltning first reported a position in Evolent Health in Q2 2017 and held it in 8 quarters.
Handelsinvest Investeringsforvaltning's Evolent Health position peaked at $2.27M in Q2 2017.
167 funds tracked by Wall St. Rank held Evolent Health as of Q4 2019.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q4 2019, filed 30 Jan 2020.